Ms. Andor will lead the Company’s expanding Clinical Operations function in support of the ongoing Phase 3 program evaluating oral levosimendan (TNX-103) for the treatment of pulmonary hypertension ...

Currently, SAGE has two FDA-approved drugs with Zulresso and Zurzuvae, and both were developed for PPD. However, Zulresso was discontinued last December, which is why SAGE doubled down on Zurzuvae.

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...